Latest Breaking News On - Metastatic colorectal - Page 1 : comparemela.com

Europe Recommends Three Cancer Drugs

The European Medicines Agency has recommended Fruzaqla, Truqap, and Eribulin Baxter for use in the treatment of specific colorectal and breast cancers.

Eribulin baxterEuropean medicines agencyEuropean unionCommittee for medicinal products human useMedicinal productsHuman useMetastatic colorectalBreast cancerAlignant breast neoplasmBreast carcinomaColorectal cancerColorectal cancer crcAlignant neoplasiaAlignant neoplasmAdvanced breast cancerMetastatic breast carcinoma

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

RAS-mutated mCRC– In RAS-mutated mCRC, novel preclinical finding demonstrates onvansertib inhibits the tumor’s ability to adapt to hypoxia resulti.

San diegoUnited statesJames levineKiki patelMark erlanderAmerican association for cancer researchOnline programGilmartin groupTaft communicationsCardiff oncology incAmerican associationCancer researchChief executive officerBev revealedNew roleHypoxia pathway

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoJames levineKiki patelMark erlanderTaft communicationsGilmartin groupAmerican association for cancer researchOnline programCardiff oncology incOncology presents novel preclinical dataSupports ongoing first lineAmerican associationCancer researchChief executive officerBev revealed

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoMark erlanderKiki patelAmerican association for cancer researchGrace spencertaft communicationsCardiff oncology incPharmd gilmartin groupAmerican associationCancer researchChief executive officerBev revealedNew roleHypoxia pathwayMetastatic colorectalCardiff oncology

Tisotumab vedotin by Genmab for Metastatic Colorectal Cancer: Likelihood of Approval

Tisotumab vedotin is under clinical development by Genmab and currently in Phase II for Metastatic Colorectal Cancer.

Tisotumab vedotin tivdakTisotumab vedotinGlobaldata pharmaceutical intelligence centerMetastatic colorectalMetastatic colorectal cancerPhase transition success rate modelTissue factorPharmaceutical intelligence